Skip to main content
. 2018 Aug 31;13(8):e0203213. doi: 10.1371/journal.pone.0203213

Table 3. Associations of serum K, rs5215, and rs5219 with incident diabetes in 11,812 ARIC-JHS participants, overall and by race.

Minimally Adjusted, Model 1 Overall P-value Whites P-
value
Blacks P-
value
Serum K (mmol/L) OR (95% CI) OR (95% CI) OR (95% CI)
2.5 ≤ K < 4.1 1.39 (1.23, 1.57) 0.000 1.36 (1.17, 1.58) 0.000 1.37 (1.08, 1.75) 0.010
4.1 ≤ K < 4.4 1.18 (1.06, 1.32) 0.004 1.18 (1.04, 1.34) 0.012 1.17 (0.91, 1.49) 0.217
4.4 ≤ K < 4.7 1.12 (1, 1.25) 0.059 1.16 (1.02, 1.32) 0.021 0.97 (0.74, 1.27) 0.827
4.7 ≤ K ≤ 5.5 1 (ref) 1 (ref) 1 (ref)
rs5215 0.98 (0.92, 1.05) 0.563 0.99 (0.92, 1.06) 0.794 0.92 (0.76, 1.11) 0.386
rs5219 0.99 (0.92, 1.06) 0.732 0.99 (0.92, 1.06) 0.702 1.02 (0.82, 1.25) 0.887
Minimally Adjusted, Model 2 with both K and SNP
Serum K (mmol/L)
2.5 ≤ K < 4.1 1.39 (1.23, 1.57) 0.000 1.36 (1.17, 1.58) 0.000 1.37 (1.08, 1.75) 0.010
4.1 ≤ K < 4.4 1.18 (1.06, 1.32) 0.004 1.18 (1.04, 1.34) 0.012 1.17 (0.91, 1.49) 0.216
4.4 ≤ K < 4.7 1.12 (1, 1.25) 0.060 1.16 (1.02, 1.32) 0.022 0.97 (0.74, 1.27) 0.823
4.7 ≤ K ≤ 5.5 1 (ref) 1 (ref) 1 (ref)
rs5215 0.98 (0.92, 1.05) 0.569 0.99 (0.92, 1.06) 0.810 0.92 (0.76, 1.11) 0.382
Serum K (mmol/L)
2.5 ≤ K < 4.1 1.39 (1.23, 1.57) 0.000 1.36 (1.17, 1.58) 0.000 1.37 (1.08, 1.75) 0.010
4.1 ≤ K < 4.4 1.18 (1.06, 1.32) 0.004 1.18 (1.04, 1.34) 0.012 1.17 (0.91, 1.48) 0.217
4.4 ≤ K < 4.7 1.12 (1, 1.25) 0.060 1.16 (1.02, 1.32) 0.022 0.97 (0.74, 1.27) 0.828
4.7 ≤ K ≤ 5.5 1 (ref) 1 (ref) 1 (ref)
rs5219 0.99 (0.93, 1.06) 0.751 0.99 (0.92, 1.06) 0.715 1.02 (0.83, 1.26) 0.828
Fully Adjusted, Model 3
Serum K (mmol/L)
2.5 ≤ K < 4.1 1.21 (1.05, 1.4) 0.008 1.18 (0.99, 1.41) 0.062 1.2 (0.92, 1.58) 0.187
4.1 ≤ K < 4.4 1.3 (1.15, 1.47) 0.000 1.25 (1.08, 1.45) 0.002 1.29 (0.99, 1.68) 0.063
4.4 ≤ K < 4.7 1.14 (1.01, 1.3) 0.033 1.15 (1, 1.32) 0.046 1 (0.75, 1.34) 0.997
4.7 ≤ K ≤ 5.5 1 (ref) 1 (ref) 1 (ref)
rs5215 1.01 (0.94, 1.08) 0.843 1.02 (0.94, 1.1) 0.663 0.93 (0.76, 1.15) 0.511
rs5219 1.02 (0.95, 1.1) 0.590 1.01 (0.94, 1.09) 0.741 1.08 (0.86, 1.36) 0.520
Fully Adjusted, Model 4 with both K and SNP
Serum K (mmol/L)
2.5 ≤ K < 4.1 1.21 (1.05, 1.4) 0.008 1.18 (0.99, 1.41) 0.062 1.2 (0.92, 1.57) 0.187
4.1 ≤ K < 4.4 1.3 (1.15, 1.47) 0.000 1.25 (1.09, 1.45) 0.002 1.29 (0.99, 1.68) 0.063
4.4 ≤ K < 4.7 1.14 (1.01, 1.3) 0.033 1.15 (1, 1.32) 0.045 1 (0.75, 1.34) 1.000
4.7 ≤ K ≤ 5.5 1 (ref) 1 (ref) 1 (ref)
rs5215 1.01 (0.94, 1.08) 0.819 1.02 (0.94, 1.1) 0.638 0.93 (0.76, 1.14) 0.505
2.5 ≤ K < 4.1 1.21 (1.05, 1.4) 0.008 1.18 (0.99, 1.41) 0.062 1.2 (0.92, 1.58) 0.183
4.1 ≤ K < 4.4 1.3 (1.15, 1.47) 0.000 1.25 (1.09, 1.45) 0.002 1.29 (0.99, 1.68) 0.063
4.4 ≤ K < 4.7 1.14 (1.01, 1.3) 0.032 1.15 (1, 1.32) 0.045 1 (0.75, 1.34) 0.998
4.7 ≤ K ≤ 5.5 1 (ref) 1 (ref) 1 (ref)
rs5219 1.02 (0.95, 1.1) 0.571 1.01 (0.94, 1.1) 0.717 1.08 (0.86, 1.36) 0.509

Model 1- adjusted for age, sex, race (overall only), SNPs and serum K analyzed in separate models

Model 2- adjusted for age, sex, race (overall only), SNP (rs5215 or rs5219), K

Model 3- adjusted for age, sex, race (overall only), BMI, systolic blood pressure, presence of hypertension, use of ABD medications, serum creatinine, serum sodium, fasting glucose, fasting insulin, parental history of diabetes mellitus, physical activity, income, SNPs and serum K analyzed in separate models

Model 4- adjusted for age, sex, race (overall only), BMI, systolic blood pressure, presence of hypertension, use of ABD medications, serum creatinine, serum sodium, fasting glucose, fasting insulin, parental history of diabetes mellitus, physical activity, income, SNP (rs5215 or rs5219), K